Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease
S Rombouts, F Barkhof, CS Van Meel… - Journal of Neurology …, 2002 - jnnp.bmj.com
Background: Rivastigmine enhances cholinergic activity and has been shown in clinical
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease
S Rombouts, F Barkhof, CS van Meel… - Journal of Neurology …, 2002 - search.proquest.com
Background: Rivastigmine enhances cholinergic activity and has been shown in clinical
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
[HTML][HTML] Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease
S Rombouts, F Barkhof, CS van Meel… - Journal of Neurology …, 2002 - ncbi.nlm.nih.gov
Background: Rivastigmine enhances cholinergic activity and has been shown in clinical
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
S Rombouts, F Barkhof, CS van Meel… - Journal of Neurology …, 2002 - psycnet.apa.org
Objectives: To use fMRI to study brain activation with rivastigmine treatment. Methods: The
effect on brain activation of a single dose of rivastigmine was tested in seven patients with …
effect on brain activation of a single dose of rivastigmine was tested in seven patients with …
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease
SARB Rombouts, F Barkhof… - Journal of …, 2002 - researchinformation.amsterdamumc …
Background: Rivastigmine enhances cholinergic activity and has been shown in clinical
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
S Rombouts, F Barkhof, CS van Meel… - Journal of Neurology …, 2002 - go.gale.com
Background: Rivastigmine enhances cholinergic activity and has been shown in clinical
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
[PDF][PDF] Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease
S Rombouts, F Barkhof, CS van Meel… - J Neurol Neurosurg …, 2002 - researchgate.net
Background: Rivastigmine enhances cholinergic activity and has been shown in clinical
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
SA Rombouts, F Barkhof, CS Van Meel… - Journal of Neurology …, 2002 - europepmc.org
BACKGROUND: Rivastigmine enhances cholinergic activity and has been shown in clinical
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
trials to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in …
[引用][C] Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease
SARB ROMBOUTS, F BARKHOF… - Journal of …, 2002 - pascal-francis.inist.fr
Alterations in brain activation during cholinergic enhancement with rivastigmine in
Alzheimer's disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Alzheimer's disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease
S Rombouts, F Barkhof… - Journal of …, 2002 - pubmed.ncbi.nlm.nih.gov
Background Rivastigmine enhances cholinergic activity and has been shown in clinical trials
to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in the …
to decrease the rate of deterioration in Alzheimer's disease. It remains unclear where in the …